Protect - The Impact of a High Protein Diet on Preservation of Muscle Mass
NCT ID: NCT01915030
Last Updated: 2013-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2012-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High protein diet
High protein diet during caloric restriction
High protein diet
controlled feeding trail. Both arms are caloric restricted
Standard protein diet
Standard protein diet during caloric restriction
standard protein diet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High protein diet
controlled feeding trail. Both arms are caloric restricted
standard protein diet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Waist circumference male:≥ 102 cm, female: ≥ 88 cm
* Willingness and ability to comply with the protocol
Exclusion Criteria
* Co-morbidities
* Type 1 \& 2 diabetics (Fasting glucose level ≥ 7 mmol/L)
* Cancer
* COPD
* Participation in weight loss program 3 months before the intervention
* Participation of any heavy resistance-type exercise training (\>1 wk) the last 2 y.
* Intentional or unintentional weight loss (\> 3 kg in the last 3 months)
* Severe loss appetite
* Diagnosed allergy to milk products
* Gastric bypass
* Supplements or medication use for weight loss
* Participation in any other intervention trial
* Women can only participate if they are postmenopausal (last period ≥ a year ago)
55 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
Top Institute Food and Nutrition
OTHER
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisette de Groot, professor
Role: PRINCIPAL_INVESTIGATOR
Prof. Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wageningen University
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WM002-wp3
Identifier Type: -
Identifier Source: org_study_id